Value Partners Investments Inc.

Position in NVS — Novartis AG

CIK 1800916 WINNIPEG, A2

Position in NVS

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$1,951,164

+$99,682 QoQ

Shares Held

12,450

+2.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#439

of 1,603 holders

Holding Since

Jun 2022

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Value Partners Investments Inc. holds $22,889,378 across 5 Drug Manufacturers - General names. NVS ranks #5 (8.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	58,251	$11,045,554
2	PFE	Pfizer Inc	164,000	$3,949,120
3	LLY	ELI LILLY & Co	2,976	$3,569,503
4	MRK	Merck & Co., Inc.	18,475	$2,374,037
5	NVS	Novartis AG This page	12,450	$1,951,164

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,951,164	12,450	+2.7%	Shares	Sole	2026-07-15
2026-03-31	$1,851,482	12,121	+10.1%	Shares	Sole	2026-04-21
2025-12-31	$1,517,948	11,010	+18.9%	Shares	Sole	2026-01-08
2025-09-30	$1,187,374	9,259	+10.3%	Shares	Sole	2025-10-15
2025-06-30	$1,015,394	8,391	+18.3%	Shares	Sole	2025-07-07
2025-03-31	$790,839	7,094	+51.2%	Shares	Sole	2025-04-23
2024-12-31	$456,675	4,693	+0.7%	Shares	Sole	2025-02-13
2024-09-30	$535,993	4,660	+2.6%	Shares	Sole	2025-02-21
2024-06-30	$483,328	4,540	+19.0%	Shares	Sole	2025-02-21
2024-03-31	$369,024	3,815	+6.5%	Shares	Sole	2025-02-21
2023-12-31	$361,573	3,581	-2.3%	Shares	Sole	2024-05-02
2023-09-30	$373,520	3,667	+3.0%	Shares	Sole	2023-10-26
2023-06-30	$359,340	3,561	+15.4%	Shares	Sole	2023-07-20
2023-03-31	$283,912	3,086	+2.0%	Shares	Sole	2023-05-01
2022-12-31	$274,428	3,025	-10.9%	Shares	Sole	2023-01-09
2022-09-30	$258,053	3,395	+11.9%	Shares	Sole	2022-10-21
2022-06-30	$256,464	3,034	—	Shares	Sole	2022-07-19
No filing history on record for this holder in this stock.